Prostate cancer prevention through pomegranate fruit

Cell Cycle

Volumn 5, Issue 4, 2006, Pages 371-373

  Malik, Arshi ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apoptosis; Chemoprevention; Chemotherapy; Pomegranate; Prostate cancer

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PLANT EXTRACT; POMEGRANATE FRUIT EXTRACT; PROSTATE SPECIFIC ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER GRAFT; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG INHIBITION; GROWTH INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; OUTCOME ASSESSMENT; POMEGRANATE; PROSTATE CANCER; PROSTATE CARCINOMA; SHORT SURVEY; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH;

ANIMALIA; LYTHRACEAE; MUS MUSCULUS; PUNICA GRANATUM;

EID: 33645243020     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.4.2486     Document Type: Short Survey

References (27)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30.
2. Saleem M, Adhami VM, Siddiqui IA, Mukhtar H. Tea beverage in chemoprevention of prostate cancer: A mini-review. Nutr Cancer 2003; 47:13-23.
3. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278:1073-77.
4. Parnes HL, Thompson IM, Ford LG. Prevention of hormone-related cancers: Prostate cancer. J Clin Oncol 2005; 23:368-77.
5. Mukhtar H, Ahmad N. Cancer chemoprevention: Future holds in multiple agents. Toxicol Appl Pharmacol 1999; 158:207-10.
6. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3:768-80.
7. Greenwald P. Lifestyle and medical approaches to cancer prevention. Recent Results Cancer Res 2005; 166:1-15.
8. Klein EA, Thompson IM. Update on chemoprevention of prostate cancer. Curr Opin Urol 2004; 14:143-9.
9. Parnes HL, House MG, Kagan J, Kausal DJ, Lieberman R. Prostate cancer chemoprevention agent development: The National Cancer Institute, Division of Cancer Prevention portfolio. J Urol 2004; 171:S68-74.
10. Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kedar AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 2000; 10:4581-9.
11. Afaq F, Saleem M, Krueger C, Reed J, Mukhtar H. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Intl J of cancer 2005; 113:423-33.
12. Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 2001; 158:195-8.
13. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci 2001; 98:10350-55.
14. Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 2004; 64:8715-22.
15. Caporali A, Davalli P, Astancolle S, D'Arca D, Brausi M, Bettuzzi S, Corti A. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin overexpression. Carcinogenesis 2004; 11:2217-24.
16. Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: A case-control study in southeast China. Int J Cancer 2004; 108:130-5.
17. Jones SB, DePrimo SE, Whitfield ML, Brooks JD. Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 2005; 14:596-4.
18. Stewart JR, Artime MC, O'Brian CA. Resveratrol: A candidate nutritional substance for prostate cancer prevention. J Nutr 2003; 133:2440S-3S.
19. Ratan HL, Steward WP, Gescher AJ, Mellon JK. Resveratrol-a prostate cancer chemopreventive agent? Urol Oncol 2002; 7:223-7.
20. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci 2005; 102:14813-8.
21. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaseili KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH. An inhibitor of Bcl-2 family proteins induces regression of solid tumors. Nature 2005; 435:677-81.
22. Gupta S, Afaq F, Mukhtar H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 2002; 21:3727-38.
23. Adhami VM, Ahmad N, Mukhtar H. Molecular targets for green tea in prostate cancer prevention. J Nutr 2003; 133:2417S-24S.
24. Chiao JW, Wu H, Ramaswamy G, Conaway CC, Chung FL, Wang L, Liu D. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 2004; 25:1403-08.
25. Sanchez I, Dynlacht BD. New insights into cyclins, Cdks, and cell cycle control. Semin Cell Dev Biol 2005; 16:311-21.
26. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends Cell Biol 2003; 13:65-70.
27. 1-phase arrest of cell cycle and inhibits matrix metalloptoteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Arch Biochem Biophys 2005; 435:264-72.